Cellebrite DI Ltd. (CLBT) Tops Q4 EPS by 3c ; Offers Guidance

Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q4 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $125.92 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q1 2026 revenue of $126-128 million, versus the consensus of $125.2 million.

Cellebrite DI Ltd. sees FY2026 revenue of $565-571 million, versus the consensus of $554.5 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Edgewell stock surges on report of rejected takeover bid